Medcash Healthtech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 80.00 K
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 195.78%
- Profit Growth 862.55%
- Ebitda 685.49%
- Net Worth 797.27%
- Total Assets 210.65%
About Medcash Healthtech
Medcash Healthtech Private Limited (MHPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 May 2017 (Seven years and eight months 29 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 80.00 K , as per Ministry of Corporate Affairs (MCA) records.
Chinmay Gheewala, Rajendra Dandekar, and Gaurav Pathak serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2017PTC295488
- Company No.
295488
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Medcash Healthtech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Pathak  | Director | 06-Feb-2020 | Current |
| Chinmay Gheewala | Director | 29-May-2017 | Current |
| Rajendra Dandekar | Director | 29-May-2017 | Current |
Financial Performance of Medcash Healthtech.
Medcash Healthtech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 195.78% increase. The company also saw a substantial improvement in profitability, with a 862.55% increase in profit. The company's net worth Soared by an impressive increase of 797.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medcash Healthtech?
In 2023, Medcash Healthtech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Yoscom Health Communications LlpChinmay Gheewala is a mutual person
- Nityacare Health Technologies Private Limited
Chinmay Gheewala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medcash Healthtech?
Unlock and access historical data on people associated with Medcash Healthtech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medcash Healthtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medcash Healthtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
